Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Merozyme DT Injection
Manufacturer/Marketed By : ZYMES BIOSCIENCE PVT LTD
$36.94 $20.32
Merozyme DT Injection contains an active component such as Meropenem and EDTA. Meropenem is an antibiotic used to treat various bacterial infections. It belongs to the class of medications known...
MEROPENEM,EDTA
Active Pharmaceutical Ingredient
Merozyme DT Injection
$36.94
$20.32
Merozyme DT Injection contains an active component such as Meropenem and EDTA. Meropenem is an antibiotic used to treat various bacterial infections. It belongs to the class of medications known as carbapenem antibiotics and is often prescribed to treat serious infections, including complicated skin and skin structure infections, complicated intra-abdominal infections, bacterial meningitis, and pneumonia, among others. EDTA (Ethylenediaminetetraacetic acid) is a chelating agent that binds to metal ions and is often used in clinical and laboratory settings. In the context of medication, the combination of Meropenem and EDTA is utilized in certain formulations to enhance the effectiveness of the antibiotic. Adding EDTA might serve various purposes, such as maintaining the stability of the drug or enhancing its activity against certain bacteria. Individuals with a history of hypersensitivity or allergic reactions to Meropenem or other beta-lactam antibiotics (like penicillins or cephalosporins) and EDTA should avoid its use. This medication should be used with caution or avoided in patients with conditions leading to imbalances in essential minerals like calcium, as it can chelate these minerals, impacting their levels in the body as it contains EDTA. Adjustments in dosing may be necessary for individuals with impaired kidney function as both Meropenem and EDTA are primarily excreted via the kidneys. Elderly individuals, children, and those with specific medical conditions (such as cystic fibrosis or immunocompromised states) may require special dosage adjustments or closer monitoring while using these medications.
Active Pharmaceutical Ingredient
Uses
• Pneumonia
• Complicated skin and skin structure infections
• Complicated intra-abdominal infections
• Bacterial meningitis
Benefits
Meropenem is a broad-spectrum antibiotic belonging to the carbapenem class. It works by inhibiting bacterial cell wall synthesis. It does this by binding to penicillin-binding proteins (PBPs), which are enzymes involved in the final steps of bacterial cell wall synthesis. By binding to these proteins, Meropenem disrupts the formation of the bacterial cell wall, leading to cell death and ultimately killing the bacteria. EDTA is a chelating agent, meaning it can bind to metal ions. It forms stable complexes with various metal ions, effectively sequestering them. This property of EDTA has many uses, including its ability to prevent metal-catalyzed oxidative reactions and to remove metal ions from solutions.
Side Effects
Merozyme DT Injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Diarrhea
• Nausea or vomiting
• Headache
• Rash or itching
• Injection site reactions (if administered intravenously)
• Changes in blood tests (like liver function tests)
Common Side Effects
• Severe allergic reactions (rare but can be life-threatening)
• Pseudomembranous colitis (a severe intestinal condition caused by Clostridium difficile bacteria)
• Central nervous system side effects, such as seizures (rare)
• Decreased blood cell counts (rare)
• Kidney damage or impairment in cases of overdose or extended use
• Hypocalcemia or low calcium levels in the blood due to chelation of calcium by EDTA
How To Use
Healthcare professionals typically administer Merozyme DT Injection in a hospital or clinical setting. The injection may be given as a slow infusion or intermittent intravenous (IV), depending on the treatment condition and the healthcare provider's instructions. Before administration, the healthcare professional will assess the patient's patient's medical history, current health status, and any known allergies or sensitivities.
Safety Advice
• Breast Feeding: Merozyme DT Injection can pass into breast milk, but the amount transferred is usually minimal. If this medication is used during breastfeeding, the healthcare provider will assess the risks and benefits and may monitor the baby for any adverse effects.
• Alcohol: Both Merozyme DT Injection and alcohol can have potential side effects on their own. When combined, there is an increased risk of adverse reactions, including nausea, vomiting, dizziness, and gastrointestinal disturbances. Alcohol may also exacerbate some of the side effects, such as kidney or liver toxicity.
• Liver: Merozyme DT Injection can be used in patients with liver impairment, but caution is required, and dosage adjustments may be necessary.
• Lungs: Merozyme DT Injection is primarily used for respiratory conditions and is generally considered safe for the lungs when used as directed. However, patients with lung disease should consult a doctor before using it.
• Driving: Merozyme DT Injection may cause side effects that can impair driving ability and overall alertness. Common side effects include dizziness, headache, and tremors, affecting coordination and reaction time.
• Pregnancy: Pregnant women need to consult with their healthcare providers about the potential risks and benefits of using Merozyme DT Injection during pregnancy.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.



